SavedAdd your journal

Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 4

Clinical Significance of Incidental 18-FDG Uptake in Nasopharynx on PET/CT Scanning

İMDAT YÜCE
KEREM KÖKOĞLU
ÜMMÜHAN ABDÜLREZZAK
Samet AYDEMİR
Turan ARLI
SEDAT ÇAĞLI
Pages
425–428
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Biopsy can be considered in patients who have a visible lesion in the nasopharynx examination, a history of lymphoma, and asymmetrical nasopharyngeal uptake according to the PET scan.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The necessity of biopsy in cases of incidental nasopharyngeal 18 fluorodeoxyglucose (18-FDG) uptake was investigated in this study.
📊
Key Findings & Data:Materials and Methods: A total of 27 patients, who suffered incidental 18-FDG uptake in their nasopharynx, were enrolled in the study.
💡
Conclusion & Impact:Conclusion: Biopsy can be considered in patients who have a visible lesion in the nasopharynx examination, a history of lymphoma, and asymmetrical nasopharyngeal uptake according to the PET scan.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The necessity of biopsy in cases of incidental nasopharyngeal 18 fluorodeoxyglucose (18-FDG) uptake was investigated in this study. Materials and Methods: A total of 27 patients, who suffered incidental 18-FDG uptake in their nasopharynx, were enrolled in the study. Their primary malignant diseases, physical examination findings, standardized uptake values (SUV), uptake sides, and nasopharynx biopsy results were evaluated. Results: There were 23 benign and 4 malignant tumors found on the biopsy results. A total of 10 patients had visible lesions in their physical examinations. When the data were evaluated statistically, the relationship between the visible lesion and the nasopharyngeal biopsy results was found to be significant (p<0.05). All the patients who had a malignant biopsy result also had a history of lymphoma and an asymmetrical nasopharyngeal uptake. There was no significant difference between the SUVmax value and the biopsy result. Conclusion: Biopsy can be considered in patients who have a visible lesion in the nasopharynx examination, a history of lymphoma, and asymmetrical nasopharyngeal uptake according to the PET scan.

🔖

Cite This Article

YÜCE, İ., KÖKOĞLU, K., ABDÜLREZZAK, Ü., AYDEMİR, S., ARLI, T., ÇAĞLI, S. (2019). Clinical Significance of Incidental 18-FDG Uptake in Nasopharynx on PET/CT Scanning. Erciyes Medical Journal, Cilt: 41 - Sayı: 4, 425–428. https://ajindex.com/articles/216833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 2014; 81(964): 291–8
  2. Lee N, Yoo IR, Park SY, Yoon H, Lee Y, Oh JK. Significance of Incidental Nasopharyngeal Uptake on 18F-FDG PET/CT: Patterns of Benign/Physiologic Uptake and Differentiation from Malignancy. Nucl Med Mol Imaging 2014; 49(1): 1–8
  3. Heusner TA, Hahn S, Hamami ME, Kögel S, Forsting M, Bockisch A, et al. Incidental head and neck (18)F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development? Eur J Nucl Med Mol Imaging 2009; 36(9): 1397–406
  4. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-Dglucose and MR imaging correlation. Radiology 1993; 186(1): 27–35
  5. Nair VS, Keu KV, Luttgen MS, Kolatkar A, Vasanawala M, Kuschner W, et al. An observational study of circulating tumor cells and (18)FFDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One 2013; 8(7): e67733
  6. Soussan M, Orlhac F, Boubaya M, Zelek L, Ziol M, Eder V, et al. Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer. PLoS One 2014; 9(4): e94017
  7. Kumar V, Nath K, Berman CG, Kim J, Tanvetyanon T, Chiappori AA, et al. Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med 2013; 38(3): 175–82
  8. Stangierski A, Wolinski K, Czepczynski R, Czarnywojtek A, Lodyga M, Wyszomirska A, et al. The Usefulness of Standardized Uptake Value in Differentiation between Benign and Malignant Thyroid Lesions Detected Incidentally in 18F-FDG PET/CT Examination. PLoS One 2014; 9(10): e109612
  9. Treglia G, Taralli S, Salsano M, Muoio B, Sadeghi R, Giovanella L. Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis. Radiol Oncol 2014; 48(2): 99–104
  10. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26(4): 308–14
  11. Purohit BS, Ailianou A, Dulguerov N, Becker CD, Ratib O, Becker M. FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging 2014; 5(5): 585–602
  12. Basu S, Houseni M, Alavi A. Significance of